한국어
English
日本語
中文(简体)Quninta Soft Capsules 150mg (Nintedanib Esilate)
183.12mg
Suspension · Prescription medication
Il Dong Pharmaceutical Co., Ltd.
Nintedanib esilate monohydrate is an active ingredient used in the treatment of certain cancers.
MFDS ingredient code M283528
Nintedanib esilate monohydrate belongs to a class of anticancer agents that inhibit various types of receptor tyrosine kinases. It is mainly used in cancer treatment by blocking the growth and angiogenesis of cancer cells.
This ingredient prevents the formation of blood vessels around cancer cells, reducing the supply of nutrients to cancer tissue, and blocks the signaling pathways for cancer cell growth, thus inhibiting cancer cell proliferation. This can slow down or halt the progression of cancer.
Approved uses differ by product. Check each product's information for its actual use.
Nintedanib is a multitargeted anticancer agent that inhibits multiple receptor tyrosine kinases simultaneously, and unlike single-target inhibitors, it has the characteristic of blocking various cancer growth pathways.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.